Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
ADMA Biologics Inc (ADMA) had Return on Equity of 30.78% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$510.17M |
|
$146.93M |
|
$217.41M |
|
$292.76M |
|
$318.73M |
|
$191.44M |
|
$-8.79M |
|
$182.66M |
|
$182.66M |
|
$146.93M |
|
$146.93M |
|
$146.93M |
|
$146.93M |
|
$191.44M |
|
$200.11M |
|
238.30M |
|
244.91M |
|
$0.62 |
|
$0.60 |
|
| Balance Sheet Financials | |
$466.51M |
|
$65.06M |
|
$157.73M |
|
$624.24M |
|
$69.54M |
|
$75.98M |
|
$77.38M |
|
$146.92M |
|
$477.32M |
|
$473.16M |
|
$477.32M |
|
237.87M |
|
| Cash Flow Statement Financials | |
$50.40M |
|
$-21.89M |
|
$-44.02M |
|
$103.15M |
|
$87.63M |
|
$-15.52M |
|
$20.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.71 |
|
-- |
|
-- |
|
0.14 |
|
0.17 |
|
57.39% |
|
37.53% |
|
37.53% |
|
39.22% |
|
35.80% |
|
28.80% |
|
$27.82M |
|
-- |
|
-- |
|
-- |
|
0.82 |
|
1.05 |
|
3.22 |
|
113.35 |
|
|
Return on Equity |
30.78% |
31.05% |
|
23.54% |
|
26.56% |
|
$2.01 |
|
$0.11 |
|
$0.21 |
|